ID: ALA2235244

Max Phase: Preclinical

Molecular Formula: C22H16O5

Molecular Weight: 360.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1cc(-c2ccccc2)oc2c(O)c(OCc3ccccc3)cc(O)c12

Standard InChI:  InChI=1S/C22H16O5/c23-16-11-18(15-9-5-2-6-10-15)27-22-20(16)17(24)12-19(21(22)25)26-13-14-7-3-1-4-8-14/h1-12,24-25H,13H2

Standard InChI Key:  OQHAZMRRNANBMN-UHFFFAOYSA-N

Associated Targets(non-human)

Avian myoblastosis virus polyprotein II 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 360.37Molecular Weight (Monoisotopic): 360.0998AlogP: 4.45#Rotatable Bonds: 4
Polar Surface Area: 79.90Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.88CX Basic pKa: CX LogP: 4.58CX LogD: 4.45
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: 0.89

References

1. Phosrithong N, Samee W, Ungwitayatorn J.  (2012)  3D-QSAR studies of natural flavonoid compounds as reverse transcriptase inhibitors,  21  (5): [10.1007/s00044-011-9570-z]

Source